Drug intelligence / Profile preview

Shenqi Sherong Pill

Development stage
Phase 3
Lead developer
Shanghai Hutchison Pharmaceuticals
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Shenqi Sherong Pill is a Traditional Chinese Medicine (TCM) candidate developed by Shanghai Hutchison Pharmaceuticals for the treatment of mild to moderate cervical spondylotic myelopathy (CSM). It is specifically formulated for patients presenting with the TCM syndrome of Qi deficiency, blood stasis, and kidney deficiency (气虚血瘀肾亏证). The drug is currently undergoing Phase III clinical evaluation in China to assess its efficacy and safety compared to placebo, with the goal of supporting a New Drug Application (NDA). As a TCM formulation, it likely contains multiple botanical and animal-derived ingredients intended to improve microcirculation and support neurological function in the context of spinal cord compression.

Brand names
Shenqi Sherong Pill
Other names
参芪麝蓉丸Shenqi Sherong Wan

Beyond the preview

Go deeper on Shenqi Sherong Pill.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shenqi Sherong Pill.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call